Insider · CIK 0001734339

Barclay Alec

Reports to the SEC for 1 company · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001734339

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-04-08	T2 Biosystems, Inc.P Purchase	Chief Operations Officer	PPurchase	+13K sh	$0.50	+$6,475.94	181,944.88
2022-03-14	T2 Biosystems, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+21.7K sh	—	—	180,421
2022-03-14	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−21.7K sh	—	—	21,667
2022-03-14	T2 Biosystems, Inc.F Tax Payment	Chief Operations Officer	FTax Payment	−11.4K sh	$0.36	−$4,159.792	168,993
2022-02-24	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−168K sh	—	—	336,976
2022-02-21	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−10K sh	—	—	0
2022-02-20	T2 Biosystems, Inc.Restricted Stock UnitsA Award	Chief Operations Officer	AAward	+600K sh	—	—	600,000
2021-03-17	T2 Biosystems, Inc.S Sale	Chief Operations Officer	SSale	−12.5K sh	$1.86	−$23.2K	74,420
2021-03-14	T2 Biosystems, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+21.7K sh	—	—	86,914
2021-03-14	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−21.7K sh	—	—	43,333
2021-02-24	T2 Biosystems, Inc.F Tax Payment	Chief Operations Officer	FTax Payment	−88.9K sh	$0.45	−$39.9K	158,755
2021-02-24	T2 Biosystems, Inc.Restricted Stock UnitsA Award	Chief Operations Officer	AAward	+505K sh	—	—	505,464
2021-02-24	T2 Biosystems, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+168K sh	—	—	247,633
2021-02-23	T2 Biosystems, Inc.S Sale	Chief Operations Officer	SSale	−7,280 sh	$2.06	−$15K	65,247
2021-02-21	T2 Biosystems, Inc.F Tax Payment	Chief Operations Officer	FTax Payment	−5,275 sh	$0.47	−$2,458.15	79,145
2021-02-21	T2 Biosystems, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+10K sh	—	—	72,527
2021-02-21	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−10K sh	—	—	10,000
2021-02-21	T2 Biosystems, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+10K sh	—	—	84,420
2020-03-14	T2 Biosystems, Inc.Stock Option (Right to Buy)A Award	Chief Operations Officer	AAward	+130K sh	—	—	130,000
2020-03-14	T2 Biosystems, Inc.Restricted Stock UnitsA Award	Chief Operations Officer	AAward	+65K sh	—	—	65,000
2020-02-24	T2 Biosystems, Inc.S Sale	Chief Operations Officer	SSale	−5,808 sh	$0.82	−$4,762.56	46,294
2020-02-21	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+10K sh	—	—	20,000
2020-02-21	T2 Biosystems, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+10K sh	—	—	52,102
2019-09-11	T2 Biosystems, Inc.S Sale	Chief Operations Officer	SSale	−4,210 sh	$2.92	−$12.3K	42,102
2019-09-11	T2 Biosystems, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+10K sh	—	—	46,312
2019-09-10	T2 Biosystems, Inc.Stock Option (Right to Buy)A Award	Chief Operations Officer	AAward	+200K sh	—	—	200,000
2019-02-21	T2 Biosystems, Inc.Restricted Stock UnitsA Award	Chief Operations Officer	AAward	+30K sh	—	—	30,000
2019-02-21	T2 Biosystems, Inc.Stock Option (Right to Buy)A Award	Chief Operations Officer	AAward	+60K sh	—	—	60,000
2018-09-12	T2 Biosystems, Inc.F Tax Payment	Chief Operations Officer	FTax Payment	−3,522 sh	$6.49	−$22.9K	33,633
2018-09-11	T2 Biosystems, Inc.Restricted Stock UnitM Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−10K sh	—	—	10,000
2018-09-11	T2 Biosystems, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+10K sh	—	—	37,155
2018-07-20	T2 Biosystems, Inc.F Tax Payment	Chief Operations Officer	FTax Payment	−7,824 sh	$6.72	−$52.6K	27,155
2018-06-28	T2 Biosystems, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+24.1K sh	—	—	34,979
2018-06-06	T2 Biosystems, Inc.A Award	Chief Operations Officer	AAward	+13.6K sh	—	—	15,301
2018-06-06	T2 Biosystems, Inc.F Tax Payment	Chief Operations Officer	FTax Payment	−4,408 sh	$8.53	−$37.6K	10,893
2018-03-15	T2 Biosystems, Inc.Performance Restricted Stock UnitsA Award	Chief Operations Officer	AAward	+96.3K sh	—	—	96,344

Recent filings

Accepted (ET)
Apr 114
Barclay Alec0000899243-22-014418
SEC(opens sec.gov)
Mar 304
Barclay Alec0000899243-22-012779
SEC(opens sec.gov)
Feb 284
Barclay Alec0000899243-22-008057
SEC(opens sec.gov)
Feb 234
Barclay Alec0000899243-22-007494
SEC(opens sec.gov)
Mar 184
Barclay Alec0000899243-21-012548
SEC(opens sec.gov)
Mar 164
Barclay Alec0000899243-21-011890
SEC(opens sec.gov)
Feb 264
Barclay Alec0000899243-21-008402
SEC(opens sec.gov)
Feb 234
Barclay Alec0000899243-21-007771
SEC(opens sec.gov)
Mar 184
Barclay Alec0000899243-20-008867
SEC(opens sec.gov)

Companies

T2 Biosystems, Inc.Chief Operations Officer

Address

101 HARTWELL AVENUE

LEXINGTON, MA, 02421